Search
for
Sort by
Research 121–150 of 1000+
- Dermatology of androgen-related disorders
- Epidemiology and treatment modalities for the management of benign prostatic hyperplasia
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Androgenetic Alopecia Treated With Topical Minoxidil. A Case Report and Review of Treatment Options
- Saw palmetto extract: A dermatologist's perspective
- Urological Oncology: Prostate Cancer
- Prostate cancer prevention
- ANTIALOPECIA ACTIVITY EXPLORATION BY In-silico ANALYSIS OF BIOACTIVE COMPOUNDS FROM Sansevieria trifasciata PRAIN LEAVES THROUGH 5α-REDUCTASE INHIBITION
- Management of male pattern hair loss.
- Five-alpha-reductase Inhibitors for prostate cancer prevention.
- Alopecia fibrosante frontal. Estudio de 12 casos en la Argentina
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- Hair loss in women with hyperandrogenism: Four cases responding to finasteride
- Enzymology of the hair follicle.
- 5-Alpha-Reductase Inhibitors in the Treatment of Male Androgenetic Alopecia: Clinical Experience
- [Androgenetic alopecia].
- Evaluation of 5α-reductase inhibitory activity of certain herbs useful as antiandrogens
- Steroid Hormones
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Clinical biochemistry of dihydrotestosterone
- Geranylated Coumarins From Thai Medicinal Plant Mammea siamensis With Testosterone 5α-Reductase Inhibitory Activity
- Persistent Erectile Dysfunction after Discontinuation of 5-Alpha Reductase Inhibitor Therapy in Rats Depending on the Duration of Treatment
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia
- Risk of rhabdomyolysis from 5-α reductase inhibitors
- Classification scale for male and female androgenetic alopecia.
- Effect of the multifunctional cosmetic ingredient sphinganine on hair loss in men and women with diffuse hair reduction
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- The Biology and Genomics of Human Hair Follicles: A Focus on Androgenetic Alopecia
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Reply by the authors